FDA Clearance Tracker · P010012-S160
ACUITY SPIRAL HEART FAILURE LEAD MODELS, 4591, 4592 AND 4593
Last checked: Nov 20, 2026Latest source record: May 16, 2008 (this decision)Source: openFDAMethods & limitations
Decided
May 16, 2008
Approved
Time to decision
220 days
Received Oct 9, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P010012-S160
- Device name
- ACUITY SPIRAL HEART FAILURE LEAD MODELS, 4591, 4592 AND 4593
- Applicant
- Boston Scientific Corp
- Applicant location
- St Paul, MN
- Received
- Oct 9, 2007
- Decided
- May 16, 2008
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Original approval
- P010012
Device type
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR THE ACUITY SPIRAL LEAD MODEL 4591, 4592, AND 4593. THE DEVICE IS INDICATED FOR CHRONIC, LEFT-VENTRICULAR PACING AND SENSING VIA THE CORONARY VEINS WHEN USED IN CONJUNCTION WITH A COMPATIBLE PULSE GENERATOR.
Source documents
Other decisions for Boston Scientific Corp
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P130030 · Decided Mar 10, 2026 · 4,453 days after receipt
Device type: STENT, CORONARY (MAF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.